Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G S Schneiderman

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|April 1, 1996
Radioiododeoxyuridine in cancer therapy: an in vitro approach to developing in vivo strategiesM H Schneiderman, G S Schneiderman
Radiation Research|May 1, 1984
G2 cells: progression delay and survivalM H Schneiderman, G S Schneiderman
Radiation Research|November 1, 1988
Cell progression after selective irradiation of DNA during the cell cycleM H Schneiderman, K G Hofer, G S Schneiderman
Radiation Research|March 22, 2001
Targets for radiation-induced cell death: when DNA damage doesn't killM H Schneiderman, K G Hofer, G S Schneiderman
International Journal of Radiation Biology|February 1, 1991
An in vitro 125IUdR-release assay for measuring the kinetics of cell deathM H Schneiderman, K G Hofer, G S Schneiderman
Radiation Research|June 1, 1990
Association between the division delay target and DNA late in the cell cycleM H Schneiderman, K G Hofer, G S Schneiderman
Cell and Tissue Kinetics|January 1, 1983
A cell kinetic method for the mitotic selection of treated G2 cellsM H Schneiderman, G S Schneiderman, C M Rusk
Radiation Research|January 1, 1996
The presence of DNA breaks and the formation of chromatid aberrations after incorporation of 125IdUrd may be necessary but are not sufficient to block cell cycle progression in G2 phaseM H Schneiderman, G S Schneiderman, M C Mühlmann-Díaz, et al.
Radiation Research|February 11, 1998
Cell cycle-based purging of lymphoma cells from bone marrow harvests using radioiodinated 5-iodo-2'-deoxyuridineM H Schneiderman, J D Jackson, S S Joshi, et al.
Acta Oncologica (Stockholm, Sweden)|January 1, 1996
On the safety of 5-[125I]iodo-2'-deoxyuridine--Preclinical evaluation in swineJ Baranowska-Kortylewicz, G V Dalrymple, K A Harrison, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|April 1, 1996
Radioiododeoxyuridine in cancer therapy: an in vitro approach to developing in vivo strategiesM H Schneiderman, G S Schneiderman
Radiation Research|May 1, 1984
G2 cells: progression delay and survivalM H Schneiderman, G S Schneiderman
Radiation Research|November 1, 1988
Cell progression after selective irradiation of DNA during the cell cycleM H Schneiderman, K G Hofer, G S Schneiderman
Radiation Research|March 22, 2001
Targets for radiation-induced cell death: when DNA damage doesn't killM H Schneiderman, K G Hofer, G S Schneiderman
International Journal of Radiation Biology|February 1, 1991
An in vitro 125IUdR-release assay for measuring the kinetics of cell deathM H Schneiderman, K G Hofer, G S Schneiderman
Radiation Research|June 1, 1990
Association between the division delay target and DNA late in the cell cycleM H Schneiderman, K G Hofer, G S Schneiderman
Cell and Tissue Kinetics|January 1, 1983
A cell kinetic method for the mitotic selection of treated G2 cellsM H Schneiderman, G S Schneiderman, C M Rusk
Radiation Research|January 1, 1996
The presence of DNA breaks and the formation of chromatid aberrations after incorporation of 125IdUrd may be necessary but are not sufficient to block cell cycle progression in G2 phaseM H Schneiderman, G S Schneiderman, M C Mühlmann-Díaz, et al.
Radiation Research|February 11, 1998
Cell cycle-based purging of lymphoma cells from bone marrow harvests using radioiodinated 5-iodo-2'-deoxyuridineM H Schneiderman, J D Jackson, S S Joshi, et al.
Acta Oncologica (Stockholm, Sweden)|January 1, 1996
On the safety of 5-[125I]iodo-2'-deoxyuridine--Preclinical evaluation in swineJ Baranowska-Kortylewicz, G V Dalrymple, K A Harrison, et al.
Pageof 1